20 December 2022
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (“MAR”), and is disclosed in accordance with the Company’s obligations under Article 17 of MAR.
Accrol Group Holdings plc
(“Accrol” or the “Company”)
Director Dealing
Accrol (AIM:ACRL), the UK’s leading independent tissue convertor, has been notified that Gareth Jenkins, the Chief Executive Officer, for personal reasons, has sold 1,000,000 ordinary shares of £0.001 each (“Ordinary Shares”) at a price of 28.0 pence per Ordinary share.
Following this disposal, Gareth is interested in 4,422,9291 Ordinary Shares representing 1.39% of the issued share capital of the Company.
1 3,741,346 of these Ordinary Shares are registered in the name of Gareth’s wife Susan Jenkins.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Gareth Jenkins |
| 2 | Reason for the notification | |
| a) | Position/status | CEO |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Accrol Group Holdings plc |
| b) | LEI | 213800MC56M5G69RJ226 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrumentIdentification code | Ordinary shares of £0.001 each ISIN: GB00BZ6VT592 |
| b) | Nature of the transaction | Sale of Ordinary shares |
| c) | Price(s) and volume(s) | Price(s)Volume(s)£0.281,000,000 |
| d) | Date of the transaction | 19 December 2022 |
| e) | Place of the transaction | London Stock Exchange, AIM |